FDA to convene advisers on review of RSV vaccines from GSK, Pfizer

The Food and Drug Administration on Wednesday said it will consult a group of vaccine and infectious disease experts on its review of two experimental vaccines for infections caused by respiratory syncytial virus, or RSV.